Back to search

Article

Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in Childhood

2024-01-31

Abstract excerpt

<h4>Background: </h4> “Rare cases of Burkitt leukemia/lymphoma (BL) exhibiting a precursor B-cell phenotype (termed herein pre-BLL) were admitted by WHO Classification of Hematopoetic and Lymphoid Tissue, recent evidence suggests that these neoplasms genetically and epigenetically resemble precursor B-cell leukemia/lymphoma (pB-acute lymphoblastic leukemia/lymphoblastic lymphoma (ALL)/LBL) rather than BL. The clin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f6b3f21b-26ee-5760-85d2-1674a6e9a06f
DOI
10.22541/au.170670574.44691886/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in ChildhoodDOI 10.22541/au.170670574.44691886/v1
Clinical Features and Treatment Strategies of Precursor B-cell Lymphoblastic Leukemia with C-myC Rearrangement in ChildhoodSemantic proximity
Leukemia burden impacts the efficacy and toxicity of blinatumomab in pediatric B-cell acute lymphoblastic leukemiaSemantic proximity
B lymphoblastic leukemia/lymphoma: new insights into genetics, molecular aberrations, subclassification and targeted therapySemantic proximity
Leukemia burden impacts the efficacy and toxicity of blinatumomab in pediatric B-cell acute lymphoblastic leukemiaSemantic proximity
Clinical Relevance and Applicability of the 2022 World Health Organization Classification of Childhood B Lymphoblastic Leukemia in the Context of MRD-Directed TherapySemantic proximity
Large B-cell lymphoma-IRF4+ in children and young people: time to reduce chemotherapy in a rare malignant mature B-cell neoplasm?Semantic proximity
[Childhood acute lymphoblastic leukemia; pathophysiology and treatment strategy].Semantic proximity
Clinical Relevance and Applicability of the 2022 World Health Organization Classification of Childhood B Lymphoblastic Leukemia in the Context of MRD-Directed TherapySemantic proximity
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.Semantic proximity
“Double hit” B-lymphoblastic lymphoma with concurrent IGH/BCL2 and 8q24/MYC translocations: a case reportSemantic proximity
BCR-ABL1 Transcript and Philadelphia Negative T-Cell Lymphoblastic Lymphoma: A Case Report and Literature ReviewSemantic proximity
Genetic features of precursor B-cell phenotype Burkitt leukemia with IGH-MYC rearrangement.Semantic proximity
Select a neighboring publication to make it the new centre.